- Home
- SLXN vs FOXO Comparison
SLXN vs FOXO Comparison
Compare SLXN & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- FOXO
- Stock Information
- Founded
- SLXN 2008
- FOXO 2019
- Country
- SLXN Israel
- FOXO United States
- Employees
- SLXN N/A
- FOXO N/A
- Industry
- SLXN
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- SLXN
- FOXO Technology
- Exchange
- SLXN NYSE
- FOXO Nasdaq
- Market Cap
- SLXN 4.3M
- FOXO 4.9M
- IPO Year
- SLXN N/A
- FOXO N/A
- Fundamental
- Price
- SLXN $1.28
- FOXO $0.15
- Analyst Decision
- SLXN Strong Buy
- FOXO
- Analyst Count
- SLXN 1
- FOXO 0
- Target Price
- SLXN $9.00
- FOXO N/A
- AVG Volume (30 Days)
- SLXN 9.6M
- FOXO 5.9M
- Earning Date
- SLXN 03-25-2025
- FOXO 11-19-2024
- Dividend Yield
- SLXN N/A
- FOXO N/A
- EPS Growth
- SLXN N/A
- FOXO N/A
- EPS
- SLXN N/A
- FOXO N/A
- Revenue
- SLXN N/A
- FOXO $1,341,000.00
- Revenue This Year
- SLXN N/A
- FOXO N/A
- Revenue Next Year
- SLXN N/A
- FOXO N/A
- P/E Ratio
- SLXN N/A
- FOXO N/A
- Revenue Growth
- SLXN N/A
- FOXO 196.03
- 52 Week Low
- SLXN $0.21
- FOXO $0.13
- 52 Week High
- SLXN $13.56
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- FOXO 36.77
- Support Level
- SLXN N/A
- FOXO $0.14
- Resistance Level
- SLXN N/A
- FOXO $0.17
- Average True Range (ATR)
- SLXN 0.00
- FOXO 0.02
- MACD
- SLXN 0.00
- FOXO 0.00
- Stochastic Oscillator
- SLXN 0.00
- FOXO 8.00
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.